Vista Partners Publishes October 2012 Newsletter
01 oct. 2012 09h15 HE
|
Vista Partners LLC
SAN FRANCISCO, CA--(Marketwire - Oct 1, 2012) - Vista Partners ("Vista") announced today that it published its FREE macroeconomic/small cap oriented monthly newsletter for the month of October....
Stellar Biotechnologies Presented at World Congress of Marine Biotechnology
26 sept. 2012 09h45 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Sep 26, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) today announced that Frank Oakes, President...
Boston Therapeutics Is Quoted as BTHE on the OTC Bulletin Board
22 mars 2012 07h00 HE
|
Boston Therapeutics, Inc.
MANCHESTER, NH--(Marketwire - Mar 22, 2012) - Boston Therapeutics, Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, is pleased to announce that the Company's common stock was quoted on...
Leading Makers of OTC Medicines Join With the National Association of School Nurses in New Effort to Prevent Teen Medicine Abuse
13 avr. 2010 11h00 HE
|
CHPA
WASHINGTON, DC--(Marketwire - April 13, 2010) - The Consumer Healthcare Products Association (CHPA) and the National Association of School Nurses (NASN) today announced the launch of "Home to...
Statement From the Consumer Healthcare Products Association on Today's Joint FDA Advisory Committee Recommendations on Over-the-Counter Medicines Containing Acetaminophen
30 juin 2009 19h00 HE
|
Consumer Healthcare Products Association
WASHINGTON, DC--(Marketwire - June 30, 2009) - Following is a statement by Linda A. Suydam,
D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding the
recommendations...
HemaQuest Pharmaceuticals Receives Orphan Drug Designations for Therapeutic to Treat Hemoglobin Disorders
04 nov. 2008 09h00 HE
|
HemaQuest Pharmaceuticals
BOSTON, MA--(Marketwire - November 4, 2008) - HemaQuest Pharmaceuticals today announced that
the U.S. Food and Drug Administration (FDA) has awarded the company orphan
drug designations for sickle...
HemaQuest Announces Initiation of Phase I Clinical Trial of HQK-1001 to Treat Hemoglobin Disorders
17 janv. 2008 09h00 HE
|
HemaQuest Pharmaceuticals
NEWTON, MA--(Marketwire - January 17, 2008) - HemaQuest Pharmaceuticals, which received its
first round of venture financing three months ago, today announced that the
U.S. Food and Drug...
HemaQuest Announces $20M Series A Financing for Anemia Drug Development
01 nov. 2007 10h30 HE
|
HemaQuest Pharmaceuticals
NEWTON, MA--(Marketwire - November 1, 2007) - HemaQuest Pharmaceuticals, a new company
developing proprietary small molecule therapeutics to treat serious blood
disorders, today announced that it...
LifePoint Announces Appointment of Chairman of the Board and New Outside Director
29 sept. 2003 08h30 HE
|
LifePoint, Inc.
ONTARIO, Calif., Sept. 29, 2003 (PRIMEZONE) -- LifePoint, Inc. (AMEX:LFP), a leader in non-invasive drug diagnostic technologies and solutions, announced today the appointment of director Stan...
LifePoint Closes on $13 Million Equity Private Placement
24 sept. 2003 08h30 HE
|
LifePoint, Inc.
ONTARIO, Calif., Sept. 24, 2003 (PRIMEZONE) -- LifePoint, Inc. (AMEX:LFP), a leader in non-invasive drug diagnostic technologies and solutions, announced today that it has completed the final close...